NIH-funded research U01 cooperative agreement

Understanding why Alaska Native adults face higher colorectal cancer risk

Official title: Building a Cancer Epidemiology Cohort to Investigate Factors Associated with Higher Risk of Colorectal Cancer among Alaska Native People

Funded at Alaska Native Tribal Health Consortium · NIH-11123433 · Data updated 2026-11-12

This project will enroll Alaska Native adults before colonoscopy to look for health, lifestyle, and biological factors linked to higher colorectal cancer risk.

More Colorectal Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionAlaska Native Tribal Health Consortium
NIH-funded
Lab location1 site (Anchorage, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$445,530
NIH project number5U01CA290673-02
Project IDNIH-11123433 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are Alaska Native adults aged 21 and older who are scheduled for screening or diagnostic colonoscopy at participating Anchorage or regional Tribal hospitals and willing to provide health information and samples.

Less likely to help

People younger than 21, non-Alaska Native individuals, or those not undergoing colonoscopy or unwilling to share medical information or samples are unlikely to benefit from or participate in this cohort.

What this research studies

You would be part of a community-led effort that enrolls 1,000 Alaska Native adults at sites in Anchorage and three to four regional Tribal hospitals before they have a colonoscopy. Researchers will collect medical history, lifestyle information, and biological samples at baseline and link those findings to colonoscopy results, with follow-up over time for new colorectal cancers and advanced adenomas. The project is led by the Alaska Native Tribal Health Consortium in partnership with Fred Hutchinson Cancer Center and builds on prior pilot recruitment work. The team uses community engagement and culturally appropriate methods so results can guide prevention, risk prediction, and early detection for Alaska Native people.

Why it matters

Potential benefit: If successful, the work could point to preventable causes and better screening strategies that reduce colorectal cancer cases and deaths among Alaska Native people.

How similar studies have gone: This is the first cohort focused specifically on Alaska Native people; while cohort studies in other populations have identified colorectal cancer risk factors, this approach is new for this community.

Where this research is happening

  • Alaska Native Tribal Health Consortium
    Anchorage, United States
    Active

Researchers

  • Principal investigator: Redwood, Diana — Alaska Native Tribal Health Consortium
  • Study coordinator: Redwood, Diana

Related research

Other NIH-funded projects on the same topics.

  • Improving colorectal cancer screening and follow-up care.

    This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.

    NIH research Research Triangle Institute · Research Triangle Park, United States · NIH-9627071

  • Colorectal cancer prognosis through a broad, collaborative study

    A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11590756

  • Ceramides and how they affect metabolism and colorectal cancer in adults

    A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11535283

  • Automated point-of-care DNA methylation test for colorectal cancer in LMICs

    A fast, affordable blood test using DNA markers to help identify people at higher risk of colorectal cancer in low- and middle-income countries.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11531863

  • Rewiring Colorectal Cancer to Harness Therapeutic Hyperactivation

    A Yale team is exploring brain-storming new ways to treat colorectal cancer by safely boosting certain cancer signaling pathways to kill cancer cells and by reshaping cancer cell states to improve responses to existing therapies.

    NIH research Yale University · New Haven, United States · NIH-11505210

  • Comparative modeling to guide colorectal cancer screening and care

    A researcher team will use computer models to study how access to care, risk, and new screening options affect colorectal cancer outcomes and costs for adults in the US.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11495363

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.